Home › Concept › European rollout

European rollout

Between 2010 and 2020, Europe largely followed the gender-affirmative model — until Scandinavia and the UK applied the brakes based on their own evidence reviews. The Netherlands, Germany, Belgium, and France remain stuck with the dogma — institutional capture that ignores even public shifts in neighboring countries.

Rollout 2010–2020: Yogyakarta as a lever

The Netherlands led the way with the VUmc protocol (see Dutch rollout ); Germany, Belgium, Spain, and the UK followed. In 2015, the Council of Europe adopted Resolution 2048, which encouraged gender self-identification — directly inspired by the Yogyakarta Principles (an NGO document without a treaty basis). EU Directive 2018/958 obliged Member States to non-discriminate on the grounds of "gender identity" — an ideological belief elevated to EU law without any measurable marker for what "gender identity" actually is.

The Scandinavian Turnaround (2020–2024)

Sweden was first. The Statens beredning för medicinsk och social utvärdering ( SBU ) published a systematic evidence review in 2022 which concluded that the benefits of puberty blockers and hormones in minors were uncertain and the risks significant. As early as 2021, Karolinska restricted medical care for minors to research settings, following its own failed attempt to replicate the Dutch Protocol. Own data, own patients, own turnaround.

Finland (COHERE guideline, 2020) and Norway ( Ukom 2023 ) followed with similar restrictions. Denmark did the same in 2024. What this Scandinavian pattern has in common: national health systems that commissioned their own evidence reviews — outside of WPATH — unanimously reached the same conclusion. Not ideologically, just clinically honest.

The UK: Cass Review (2024) and Tavistock closure

The United Kingdom closed the Tavistock GIDS clinic in 2024 (see Tavistock closure ). The Cass Review recommended a return to cautious multidisciplinary care, with psychotherapy as the first option and puberty blockers only within research protocols. Cass puberty blockers (see specific page ) demonstrated that the "evidence base" was nothing more than an affirmative assumption. NICE (2020) had already laid the foundation. The BMJ published a series of scathing editorials.

Continental inertia: institutional capture

The Netherlands, Germany, Belgium, and France refuse to follow the Scandinavian line. The Dutch ZonMw report remains halfway; the Knowledge Table Transgender Care largely upholds SOC8 . In 2024, Germany adopted a Selbstbestimmungsgesetz that legally enshrines self-identification — exactly contrary to the Scandinavian signal. Belgium continues to follow the affirmative line via ZNA, Ghent, and Brussels. The consequence: the Netherlands — once a pioneer — is now structurally lagging behind countries that are correcting the error. What perpetuates the continental freeze is institutional capture: ZonMw, EAPM, ESCAP, and affirmative advocacy actively deny Cass and silence criticism.

Frequently Asked Questions